Browsing by Contributors Halperin, Jonathan L

فهرست الفبایی 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
 
Showing results 1 to 19 of 19
PreviewIssue DateTitleContributor(s)
2016 JACC Volume 67 Issue 22 June (3).pdf.jpg20162016 ACC Lifelong Learning Competencies for General CardiologistsWilliams, Eric S; Halperin, Jonathan L; Arrighi, James A; Awtry, Eric H; Bates, Eric R; Costa, Salvatore; Mcpherson, John A; Mendes, Lisa A; Ryan, Thomas; Bates, Eric R
2016 CIRC Volume 133 Issue 14 April  (4).pdf.jpg2016ACC / AHA / HRS Systematic Review Report Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation : A Systematic Review for the 2015 ACC / AHA / HRS Guideline for the Management of Adult Patients With Supraventricular TachycaHsu, Jonathan C; Halperin, Jonathan L; Levine, Glenn N; Anderson, Jeffrey L; Past, Immediate; Albert, Nancy M; Al-khatib, Sana M; Birtcher, Kim K; Bozkurt, Biykem; Brindis, Ralph G; Cigarroa, Joaquin E; Curtis, Lesley H; Fleisher, Lee A; Gentile, Federico; Gidding, Sam
2016 CIRC Volume 133 Issue 14 April  (11).pdf.jpg2016ACC / AHA Task Force Statement Further Evolution of the ACC / AHA Clinical Practice Guideline Recommendation Classification System Association Task Force on Clinical Practice Guidelines Classes of RecommendationHalperin, Jonathan L; Levine, Glenn N; Al-khatib, Sana M; Birtcher, Kim K; Bozkurt, Biykem; Brindis, Ralph G; Cigarroa, Joaquin E; Curtis, Lesley H; Fleisher, Lee A; Gentile, Federico; Gidding, Samuel; Hlatky, Mark A; Ikonomidis, John
2017 JACC Volume 69 Issue 7 February (2).pdf.jpg2017Anticoagulation in Atrial Fibrillation: Is the Paradigm Really Shifting Prakash Deedwania, Tushar Acharya 786Rowin, Ethan J; Maron, Barry J; Haas, Tammy S; Garberich, Ross F; Wang, Weijia; Link, Mark S; Maron, Martin S; Spirito, Paolo; Diener, Hans-christoph; Dubner, Sergio J; Halperin, Jonathan L; Ma, Chang Sheng
2016 JACC Volume 67 Issue 13 Supplement 1 April (928).pdf.jpg2016Arrhythmias and Clinical EP NOVEL ORAL ANTICOAGULANT AVAILABILITY INCREASES APPROPRIATE USE OFZheng, Qi; Aneke-nash, Chino; Halperin, Jonathan L; Vorchheimer, David A
2016 CIRCU Volume 133 Issue 15 April (10).pdf.jpg2016C ontroversies in C ardiovascular M edicine Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor ( CHA 2 DS 2 -VASc Score 1 in Men , 2 in Women ) Be Anticoagulated ?Halperin, Jonathan L
2017 JACC Volume 69 Issue 7 February (6).pdf.jpg2017The Changing Landscape for Stroke Prevention in AFHuisman, Menno V; Rothman, Kenneth J; Paquette, Miney; Teutsch, Christine; Diener, Hans-christoph; Dubner, Sergio J; Halperin, Jonathan L; Zint, Kristina; Elsaesser, Amelie; Bartels, Dorothee B; Lip, Gregory Y H
2015 JACC1 Volume 65 Issue 17 May (2).pdf.jpg2015COCATS 4 Task Force 1: Training in Ambulatory, Consultative, and Longitudinal Cardiovascular Care.Fuster, Valentin; Halperin, Jonathan L; Williams, Eric S; Cho, Nancy R; Iobst, William; Mukherjee, Debabrata; Vaishnava, Prashant
2015 JACC1 Volume 65 Issue 3 January (3).pdf.jpg2015Device-Detected Atrial FibrillationHalperin, Jonathan L
2013medicine article ar (499).pdf.jpg2013Do Patients with Paroxysmal Atrial Fibrillation in Sinus Rhythm during PCI Require Triple Therapy? Results from a Multicenter Center StudyMennuni, Marco G; Theodoropoulos, Kleanthis; Mehran, Roxana; Bernelli, Chiara; Colombo, Antonio; Moreno, Pedro R; Krishnan, Prakash; Kovacic, Jason; Baber, Usman; Halperin, Jonathan L; Kherada, Nisharahmed I; Sartori, Samantha; Sayeneni, Swapna; Walker, Linsey; Roy, Sw
2015 JACC1 Volume 66 Issue 21 December (27).pdf.jpg2015Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin: ROCKET AF Trial.Sherwood, Matthew W; Nessel, Christopher C; Hellkamp, Anne S; Mahaffey, Kenneth W; Piccini, Jonathan P; Suh, Eun-Young; Becker, Richard C; Singer, Daniel E; Halperin, Jonathan L; Hankey, Graeme J; Berkowitz, Scott D; Fox, Keith A A; Patel, Manesh R
2018 JACC Volume 72 Supplement 2 October  (637).pdf.jpg2018GW29-e1538 Two-year safety and effectiveness of dabigatran in Asian patients with atrial fibrillation: Phase II results from Asian countries in the GLORIA-AF Registry ProgramMa, Changsheng; Kim, Young Hoon; Higashino, Yorihiko; Shlyakhto, Evgeny V; Dubner, Sergio J; Halperin, Jonathan L; Rothman, Kenneth J; Lu, Shihai; Franca, Lionel Riou; Paquette, Miney; Teutsch, Christine; Huisman, Menno V; Lip, Gregory Y H
2017 JACcardiology Volume 70 Issue 13 September (8).pdf.jpg2017Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial FibrillationHalperin, Jonathan L; Huisman, Menno V; Lip, Gregory Y H; Nieuwlaat, Robby; D, P H
2016 CIRC Volume 133 Issue 4 January (20).pdf.jpg2016Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial FibrillationPiccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Breithardt, Günter; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, Keith A A; Patel, Manesh R
2017 JACC Volume 69 Issue 24 June (7).pdf.jpg2017Preventing Myocardial Infarction inHalperin, Jonathan L
2016 CIRCU Volume 134 Issue 2 July (14).pdf.jpg2016Response to Letter to Editor Response by Piccini et al to Letters Regarding Article , “ Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation ”Factor, Direct; Inhibition, Xa; Trial, Embolism; Piccini, Jonathan P; Hellkamp, Anne S; Washam, Jeffrey B; Becker, Richard C; Berkowitz, Scott D; Halperin, Jonathan L; Hankey, Graeme J; Hacke, Werner; Mahaffey, Kenneth W; Nessel, Christopher C; Singer, Daniel E; Fox, K
2016 CIRC Volume 134 Issue 18 November (19).pdf.jpg2016Response to Letter to the Editor Response by Halperin and Savino to Letter Regarding Article , “ Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor ( CHA 2 DS 2 -VASc Score 1 in Men , 2 in Women ) Be Anticoagulated ? The CHA 2 DS 2 -VASc 1Halperin, Jonathan L
2018 NEJM Volume 379 Issue 12 September (14).pdf.jpg2018Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessElliott, C Gregory; Halperin, Jonathan L; Hiatt, William R; Maynard, Gregory A; Steg, P Gabriel; Weitz, Jeffrey I; Suh, Eunyoung; Spiro, Theodore E; Barnathan, Elliot S
2016 JACC Volume 68 Issue 13 September (22).pdf.jpg2016Updated Clinical Practice Guidelines on Heart Failure : An International AlignmentAntman, Elliott M; Bax, Jeroen; Chazal, Richard A; Creager, Mark A; Halperin, Jonathan L; Houser, Steven; Walsh, Mary Norine; Williams, Kim A; Zamorano, Jose L